An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration ...
It took 16 years of twists and turns. Over and over, Dr. Nancy Sullivan thought she was close to an Ebola vaccine, only to see the next experiment fail.
On Dec. 26, 2013, a two-year-old boy living in the Guinean village of Meliandou, Guéckédou Prefecture was stricken with a rare disease, caused by the filament-shaped Ebola virus.
For the first time since the west African Ebola outbreak began over a year ago, a clinical trial with a candidate treatment has yielded "encouraging" results, researchers announced Thursday.
Does the blood of Ebola virus disease survivors contain antibodies and immune cells that could help doctors fight Ebola infections in other people?
Sierra Leone said on Wednesday it would reopen the country's schools on March 30, after a seven-month shutdown to limit the spread of the Ebola virus.
Only about a third of the $2.89 billion (2.52 billion euros) in aid money pledged to fight Ebola was actually delivered as of December 31, according to an analysis in the British Medical Journal.
As of Dec. 31, 2014, pledges to the Ebola outbreak reached at least $2.89 billion, yet only around two-thirds ($1.9 billion) has actually reached affected countries, finds a report published by The BMJ this week.
The first large-scale trials of two Ebola vaccines began in Liberia on Monday, the hospital hosting the research said.
Liberia's education ministry said on Sunday it had postponed by two weeks the reopening of the country's schools, which were closed six months ago to limit the spread of the Ebola virus.
(Medical Xpress)—Researchers working at Institut Pasteur in France have found that the Ebola virus is mutating "a lot" causing concern in the African countries where the virus has killed over eight thous ...
Health officials are now focused on ending the biggest-ever Ebola outbreak rather than just slowing the deadly virus' spread, the World Health Organization said Thursday.
The first results from a trial of a candidate Ebola vaccine at Oxford University suggest the vaccine has an acceptable safety profile at the doses tested, and is able to generate an immune response.
Liberia's president on Monday announced the closure of an Ebola treatment facility which lay at the epicentre of the virus's worst outbreak in history, as the disease's spread has slowed in the country.
Liberia said Monday that there are currently only five confirmed cases of Ebola in the entire country—a dramatic turnaround in the West African nation where the virus has taken its deadliest toll.